Home > Compound List > Product Information
Nialamide_Molecular_structure_CAS_51-12-7)
Click picture or here to close

Nialamide

Catalog No. DB04820 Name DrugBank
CAS Number 51-12-7 Website http://www.ualberta.ca/
M. F. C16H18N4O2 Telephone (780) 492-3111
M. W. 298.33972 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 4364

SYNONYMS

IUPAC name
N-benzyl-3-(pyridin-4-ylformohydrazido)propanamide
IUPAC Traditional name
nialamide
Brand Name
NF-xIII
Espril
Mygal
Niamid
Delmoneurina
Isalizina
Nialamid
Niamidal
Niamide
Niaquitil
Niazin
Nuredal
Nyazin
Nyezin
Psicodisten
Surgex
Novazid
Synonyms
N-isonicotinoyl-n'(beta-n-benzylcarboxamidoethyl)hydrazine
1-[2-(Benzylcarbamoyl)ethyl]-2-isonicotinoylhydrazine
2-(2-(Benzylcarbamoyl)ethyl)hydrazide isonicotinic acid
1-(2-(Benzylcarbamoyl)ethyl)-2-isonicotinoylhydrazine
2-[2-(Benzylcarbamoyl)ethyl]hydrazide isonicotinic acid
Isonicotinic acid, 2-(2-(benzylcarbamoyl)ethyl)hydrazide
Isonicotinic acid, 2-[2-(benzylcarbamoyl)ethyl]hydrazide
Lopac-N-1392
N-(2-(Benzylcarbamyl)ethylamino)isonicotinamide
N-Benzyl-3-(2-isonicotinoylhydrazino)propanamide
Nialamidum [inn-latin]
Pyridine-4-carboxylic 2-[2-(benzylcarbamoyl)ethyl]hydrazide
2-(2-(Benzylcarbamoyl)ethyl)hydrazide, isonicotinic acid
2-(2-(Benzylcarbamyl)ethyl)hydrazide isonicotinic acid
BEIH
Isonicitinic acid 2-[(2-benzylcarbamoyl)ethyl]hydrazide
Isonicotinic acid 2-((2-benzylcarbamoyl)ethyl)hydrazide
Isonicotinic acid, 2-[2- (benzylcarbamoyl)ethyl]hydrazide
Isonicotinic acid, 2-[2-(benzylcarbamoylethyl]hydrazide
Isonicotinic acid, {2-[2-(benzylcarbamoyl)ethyl]hydrazide}
Isonicotinic acid, {2-[2-(benzylcarbamoylethyl]hydrazide}
N-benzyl-beta-(isonicotinoylhydrazine)propionamide
N-isonicotinyl hydrazide
N-benzyl-beta-(isonicotinylhydrazino)propionamide
Nialamida [inn-spanish]

DATABASE IDS

PubChem SID 46506047
PubChem CID 4472
CAS Number 51-12-7

PROPERTIES

Hydrophobicity(logP) 0.87 [HANSCH,C ET AL. (1995)]

DETAILS

Description (English)
Item Information
Drug Groups withdrawn
Description Withdrawn from the Canadian, US, and UK markets in 1963 due to interactions with food products containing tyrosine.
Affected Organisms
• Humans and other mammals
References
• Benady DR, Clein LJ, Pare CM: Intramuscular nialamide in intractable depression. Dis Nerv Syst. 1965 Dec;26(12):792-4. [Pubmed]
• OULES J, CAZABON: [TREATMENT OF DEPRESSIVE STATES WITH INTRAVENOUS NIAMIDE.] Toulouse Med. 1964 Dec;65:1298-302. [Pubmed]
• VAISBERG M, McGAHEE CL, RADINGER N, SAUNDERS JC: Nialamide for the treatment of anergy and depression. Dis Nerv Syst. 1959 Aug;20(Suppl):22-5. [Pubmed]
External Links
• Wikipedia

REFERENCES

  • Benady DR, Clein LJ, Pare CM: Intramuscular nialamide in intractable depression. Dis Nerv Syst. 1965 Dec;26(12):792-4. Pubmed
  • OULES J, CAZABON: [TREATMENT OF DEPRESSIVE STATES WITH INTRAVENOUS NIAMIDE.] Toulouse Med. 1964 Dec;65:1298-302. Pubmed
  • VAISBERG M, McGAHEE CL, RADINGER N, SAUNDERS JC: Nialamide for the treatment of anergy and depression. Dis Nerv Syst. 1959 Aug;20(Suppl):22-5. Pubmed